<DOC>
	<DOCNO>NCT00292383</DOCNO>
	<brief_summary>The purpose study determine whether relationship ventricular lead position incidence heart failure atrial fibrillation patient indication permanent pacemaker stimulation .</brief_summary>
	<brief_title>Ventricular Pacing Site Selection ( V-PASS )</brief_title>
	<detailed_description>AV-Block high degree primary indication pace therapy 20 % pacemaker patient . Pacing system ventricular stimulation ( VVI VDD ) fraction 40 % pacemaker Germany . About 50 % implanted pacemaker Germany dual-chamber pacemaker one half use treatment AV block . Picture 1 : Fractions pace indication Germany Picture 2 : Fractions use pace mode Germany /1/ A lot study prove past pacing site influence development hemodynamics , heart failure ( HF ) atrial fibrillation ( AF ) . Unfortunately , result commonly applicable statistically assure . Due , examination require order get explicit statement regard application alternative , nonapical ventricular lead positioning . 1 . Pilotphase It shall determine whether randomize position ventricular lead 2 define position ( either Group A : Positioning right ventricular apex Group B : . Positioning right ventricular high septum ) feasible . Included patient already examine follow accord protocol . After proved feasibility randomize positioning , data patient shall use evaluation V-PASS study . 2 . Study Phase It shall evaluate far 2 defined different ventricular lead position permanent pacemaker therapy influence combine study endpoint mortality clinically relevant symptom heart failure . Further development hemodynamics incidence atrial fibrillation shall study .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Atrioventricular Block</mesh_term>
	<criteria>Patients expect ventricular stimulation rate &gt; 60 % plan pace therapy . This follow pacing indication Symptomatic firstdegree AV block , PQ time &gt; 250ms Seconddegree Av block permanent 2:1 conduction Permanent thirddegree AV block Paroxysmal firstdegree thirddegree Av block , anticipate rate ventricular stimulation &gt; 60 % Symptomatic bradyarrhythmia absoluta permanent atrial fibrillation , anticipated rate ventricular stimulation &gt; 60 % heart failure acc . NYHA III IV Intraatrial conduction delay ( Pwave &gt; 150ms ) Myocardial infarction le 6 month pacemaker implant hypertrophic obstructive cardiomyopathy Cardiogenic shock pregnancy Lactation period Patients 18 year age</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Cardiac Pacing , artificial</keyword>
	<keyword>Atrial Fibrillation</keyword>
	<keyword>Heart failure</keyword>
	<keyword>Pacemaker lead</keyword>
	<keyword>Lead position</keyword>
	<keyword>Higher degree AV-Block</keyword>
</DOC>